FDA seeks dismissal of Mylan's lawsuit regarding generic Lipitor

04/7/2011 | Wall Street Journal, The

The FDA petitioned a federal judge to dismiss a lawsuit from Mylan that seeks an injunction forcing the agency to deny a six-month exclusivity period for Ranbaxy Laboratories' generic version of Lipitor, Pfizer's cholesterol-lowering drug. The agency said Mylan's legal action is premature because the agency has not approved any generic Lipitor.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA